New York, NY, United States
Disclosure information not submitted.
MON-722 - GLP-1 and GLP-1/GIP Receptor Agonist Medication Use and Self-Reported Outcomes in Individuals with Lipedema: Results from A Large Online Survey
Monday, June 15, 20269:00 AM - 2:00 PM CT